Next Article in Journal
Associations of Cord Blood Lipids with Childhood Adiposity at the Age of Three Years: A Prospective Birth Cohort Study
Next Article in Special Issue
Differential Chemical Profile of Metabolite Extracts Produced by the Diaporthe citri (G-01) Endophyte Mediated by Varying the Fermented Broth pH
Previous Article in Journal
Biofluid Metabolomics and Lipidomics of Mice Exposed to External Very High-Dose Rate Radiation
Previous Article in Special Issue
Infection Biomarkers Based on Metabolomics
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Metabolites
Volume 12
Issue 6
10.3390/metabo12060521
metabolites-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Genome Features and AntiSMASH Analysis of an Endophytic Strain Fusarium sp. R1

by
Yuanyuan Liu
†,
Meijie Xu
†,
Yuqi Tang
,
Yilan Shao
,
Hong Wang
and
Huawei Zhang
*
School of Pharmaceutical Sciences, Zhejiang University of Technology, Hangzhou 310014, China
*
Author to whom correspondence should be addressed.
†
These authors contributed equally to this work.
Metabolites 2022, 12(6), 521; https://doi.org/10.3390/metabo12060521
Submission received: 10 April 2022 / Revised: 30 May 2022 / Accepted: 1 June 2022 / Published: 4 June 2022
(This article belongs to the Special Issue Metabolic Profiling towards the Development of Antibiotic Management)
Browse Figures
Versions Notes

Abstract

:
Endophytic fungi are one of the most prolific sources of functional biomolecules with therapeutic potential. Besides playing an important role in serious plant diseases, Fusarium strains possess the powerful capability to produce a diverse array of bioactive secondary metabolites (SMs). In order to in-depth mine gene clusters for SM biosynthesis of the genus Fusarium, an endophytic strain Fusarium sp. R1 isolated from Rumex madaio Makino was extensively investigated by whole-genome sequencing and in-depth bioinformatic analysis, as well as antiSMASH annotation. The results displayed that strain R1 harbors a total of 51.8 Mb genome, which consists of 542 contigs with an N50 scaffold length of 3.21 Mb and 50.4% GC content. Meanwhile, 19,333 functional protein-coding genes, 338 tRNA and 111 rRNA were comprehensively predicted and highly annotated using various BLAST databases including non-redundant (Nr) protein sequence, nucleotide (Nt) sequence, Swiss-Prot, Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG) and Clusters of Orthologous Groups (COG), as well as Pathogen Host Interactions (PHI) and Carbohydrate-Active enzymes (CAZy) databases. Antibiotics and Secondary Metabolites Analysis Shell (AntiSMASH) results showed that strain R1 has 37 SM biosynthetic gene clusters (BGCs), including 17 nonribosomal peptide synthetases (NRPSs), 13 polyketide synthetases (PKSs), 3 terpene synthases (Ts), 3 hybrid NRPS + PKS and 1 hybrid indole + NRPS. These findings improve our knowledge of the molecular biology of the genus Fusarium and would promote the discovery of new bioactive SMs from strain R1 using gene mining strategies including gene knockout and heteroexpression.

1. Introduction

Endophytic fungi have been considered one of the richest sources of natural products with diverse chemical structures and biological properties, which play a potential role in the development of new therapeutical agents [1,2,3]. The landmark in this area of endophyte bioprospecting was undoubtedly the discovery of Taxomyces andreanae, the first taxol-producing endophytic fungus from Taxus brevifolia [4]. Since then, the secondary metabolites (SMs) of endophytic microbes have received a wide range of attention. Fungi belonging to the genus Fusarium are prevalent on crops in both semitropical and temperate zones since they can infect vegetables, fruits, small grain cereals and maize, leading to vascular wilt, stem, root, and ear rot, with a serious decrease in the yields of crops and severe economic losses [5,6]. However, a great amount of evidence indicates that the genus Fusarium possesses the potential capability to produce plenty of SMs with significant bioactivities, such as antimicrobial [7,8], anticancer [9,10], antiviral [11], antioxidants [12,13], and so on.
Genome mining is one computational method for the automatic detection and annotation of biosynthetic gene clusters (BGCs) from genomic data. During the past two decades, this approach has been increasingly utilized in natural product (NP) discovery due to the large amount of genome sequencing data that is now available [14]. As a comprehensive pipeline for the automated mining of genome data for the presence of BGCs, antiSMASH (antibiotics and Secondary Metabolites Analysis Shell) has made a significant contribution to microbial genome mining for novel SM discovery [15]. The SM reservoir of Fusarium species shows these strains harbor a wide array of BGCs including polyketide synthases (PKSs), non-ribosomal peptide synthetases (NRPSs), and terpene synthases (TSs), hybrids and miscellaneous, suggesting that its biosynthetic potential goes substantially beyond compounds commonly classified as “Fusarium toxins” [16].
However, the results of our previous research are not interesting or exciting since most of these SMs that we found are polyketide compounds and other types of chemicals such as terpenes have not yet been obtained from strain R1. It suggests that most SM BGCs in strain R1 are silent or expressed at a low level under conventional cultivation conditions. In order to in-depth explore the SM biosynthetic potential of strain R1, its whole-genome sequencing and analysis, as well as antiSMASH annotation are extensively conducted in this work.

2. Results and Discussion

2.1. Identification of Strain R1

After being incubated on a PDA medium for 3 d at 28 °C, strain R1 produced white colonies with aerial mycelium and fusiform conidia (Figure 1). Phylogenetic analyses of the 18S rRNA sequence (GenBank accession no. MF376147) and the ITS sequence [17,18] (GenBank accession no. ON545070) indicated that strain R1 was unambiguously determined as Fusarium species (Figures S1 and S2).

2.2. Genome Sequencing and Assembly

The genome sequence of strain R1 was assembled and deposited in the NCBI GenBank database (SRA accession No. PRJNA608251) followed by a comprehensive analysis using the paired-end Illumina HiSeq 2500. The genome diagram of strain R1 shows that there are nine circles in the circle diagram (Figure 2), which are as follows from inside to outside: the first blue line shows in-paralog pairs (better hits to each other, and the evaluation between pairs is less than 1 × 10−5); the second circle shows the GC skew, with the green part showing a positive GC SKEW and the orange part showing a negative GC SKEW; the third circle shows the GC content; the fourth circle shows secondary metabolites; the fifth circle shows ncRNA; the sixth circle shows repeat; the seventh circle and the eighth circle display CDS annotation information, and different colors represent different COG annotation classification. The seventh circle indicates that CDS is in a negative chain, and the eighth circle indicates that CDS is in a positive chain. The outer rim shows the scaffold.
The whole-genome size of strain R1 was 51.8 Mb. This consisted of 542 contigs with an N50 of 3.21 Mb and 50.4% GC content. The results indicated that genome assembly was of high quality. A total of 58,040,324 raw reads and 54,020,630 clean reads were generated in the Illumina sequencing. We predicted 19,333 protein-coding genes, the total length of the gene was 24.69 Mb, the average sequence length was 1276.94 bp, and the longest contig length was 6.56 Mb (Table 1). We used Homology, Snap and Augustus prediction methods to predict the encoding gene. Simultaneously, the three prediction methods Proteinmask, repeatmasker and trf were used to predict repeated sequences. Proteinmask predicted that the number of repeating sequences was 1665, occupying 1.59% of the whole genome, repeatmasker predicted that the number of repeating sequences was 577, occupying 0.52% of the whole genome, trf predicted that the number of repeating sequences was 4191 occupying 0.68% of the whole genome. The number of DNA transposons was 375, occupying 0.55% of the whole genome. For non-coding RNA, we predicted 338 secondary structures of RNA and tRNA by tRNAscan, and 111 rRNA was predicted by RNAmmer. At the same time, 29 snRNA was predicted with the Rfam database by rfam_scan.

2.3. Genome Sequence Annotation

To predict protein sequences, 19,333 non-redundant genes of strain R1 were subjected to similarity analysis based on six public databases. Most genes were mapped using the Nr database (16,803 genes/86.91%), Nt (15,461 genes/79.97%), Swiss-Prot (11,026 genes/57.03%), (GO; 8780 genes/45.41%), Kyoto Encyclopedia of Genes and Genomes (KEGG; 10,894 genes/56.35%), and Clusters of Orthologous Groups (COG; 8084 genes/41.63%) (Table 1). According to the COG database, “general function prediction only” was associated with the most genes (2879) followed by “carbohydrate transport and metabolism”, “amino acid transport and metabolism”, and “transcription” as the most gene-rich classes in the COG groupings (Figure 3a) [19]. These findings suggest the presence of an enriched and varied array of carbohydrates and amino acid metabolism functions that maybe enable higher energy conversion efficiency. The KEGG functional classification showed the Global map (6064), carbohydrate metabolism (3692), and Amino acid metabolism (2075) (Figure 3b) [20]. These findings suggest the presence of an enriched and varied array of protein and lipid metabolism functions that probably enable higher secondary metabolism efficiency. GO annotation resulted in the cell (3330), membrane (3195), and organelle (2781) from the cellular component category, cellular process (4627), metabolic process (4995), and single-organism (4078) from biological processes, and binding (3567) and catalytic activity (4375) from molecular functions (Figure 3c) [21]. Strain R1 is a wild strain, in which many metabolic genes may be involved in signal transduction.

2.4. Additional Annotation

2.4.1. Pathogen Host Interactions (PHI)

The Pathogen Host Interactions Database (PHI-base) has manually curated experimentally verified pathogenicity, virulence and effector genes from fungal, bacterial and protist pathogens [22]. The amino acid sequence of the target species of strain R1 was compared with the PHI database by using the BLAST software, and the gene of the target species was combined with the functional annotation information to obtain an annotation result. As shown in (Figure 4), strain R1 harbors abundant PHI-base genes, including reduced virulence (912), increased virulence (hypervirulence) (38), loss of pathogenicity (191), mixed outcome (199), lethal (134), unaffected pathogenicity (1444), sensitivity to chemical (15), resistance to chemical (8), effector (plant avirulence determinant) (10) and enhanced antagonism (2) [23]. Reduced virulence and unaffected pathogenicity are the major annotation gene, suggesting that strain R1 is not a highly pathogenic strain.

2.4.2. Carbohydrate Genes

Carbohydrate-active enzymes (CAZy) play an important role in carbohydrate degradation, modification and biosynthesis in fungi [24]. CAZy is also a Carbohydrate Active enZYmes Database, a specialized database of carbohydrate enzymes, which includes a family of related enzymes that catalyze the degradation, modification, and biosynthesis of carbohydrates [25]. This analysis showed 1000 genes encoding carbohydrate-active enzymes (CAZy) that were distributed in strain R1. These included 457 glycoside hydrolases (GHs), 113 auxiliary activities (AAs), 195 glycosyltransferases (GTs), 61 carbohydrate esterases (CEs), 141 carbohydrate-binding modules (CBMs), and 33 polysaccharide lyases (PLs) (Figure 5). PLs were mainly distributed in six families, including PL1, PL3, PL4, PL7, PL9 and PL20. AAs mainly included AA1-9, AA11-AA13 twelve families. GTs contained 29 families, including eight chitin synthetases that belong to the GT2 family. CEs were classified as CE1-CE6, CE8-9, CE11-CE12, CE16 eleven families. GHs were distributed across 65 families. Comparing with other different fungi, strain R1 had more carbohydrate genes (Table S2). Therefore, strain R1 probably has the ability to breakdown complex carbohydrates and capture more energy.

2.5. Analysis of Secondary Metabolite Biosynthetic Gene Clusters

Basic gene findings of its genomic sequence indicated that 18,956 genes are predicted and classified into 24 types, while 907 of these functional genes are involved in SM biosynthesis, transport and catabolism. AntiSMASH analysis suggested that strain R1 possesses 37 SM biosynthetic gene clusters (BGCs), including 13 PKS (12 T1PKS and 1 T3PKS), 10 NRPS, 7 NRPS-like, 2 hybrid NRPS + T1PKS, 1 hybrid NRPS-like + T1PKS, 1 hybrid Indole + NRPS and 3 Terpene biosynthetic genes (Table S1). Only 20% of these BGCs showed gene homologies with known clusters in the MIBiG database. By further comparison with the gene sequences of other reference strains, several BGCs of strain R1 with high similarity were identified and predicted to be responsible for the biosynthesis of sansalvamide in region 3.1, NG-391 in region 4.1 and cyclosporin in region 51.2 (Figure 6) [26,27,28].
AntiSMASH analysis showed that the genes within the region 3.1 had a significant BLAST hit with the sansalvamide BGC (GenBank: NW_003315863.1) from F. solani (77-13-4; FGSC 9596). Sansalvamide, a cyclic pentadepsipeptide with a potent anticancer effect, was originally isolated from one marine Fusarium species [29]. The chemical structure of sansalvamide, with four proteogenic amino acids and one hydroxyl acid, suggests that it could be synthesized by a five-module NRPS where each of the modules would be responsible for incorporating one of the amino acids. BGC region 4.1 of strain R1 displayed significant similarity with that of NG-391 (GenBank: GQ176852.1) from Metarhizium robertsii. NG-391 is the 7-desmethyl analog of fusarin C, and like fusarin C, NG-391 is strongly mutagenic in the Ames test in the presence of the S9 fraction from rat liver [30,31,32]. Given its structural similarity to fusarin C, NG-391 is expected to be produced by a hybrid PKS–NRPS using a similar biosynthetic mechanism. Typically, these megasynthases combine a type I PKS with a single NRPS module and a C-terminal reductase domain. In addition to six ORFs, BGC region 4.1 possesses several additional enzymes including an aminotransferase class V, one cytochrome P450, and aldehyde dehydrogenase. BGC region 51.2 of strain R1 showed a highly similar sequence with the cyclosporins C BGC (GenBank: MF716954.1) from Beauveria feline. Cyclosporin C belongs to one class of cyclic depsipeptides and is used as a cyclophilin inhibitor for the prevention or treatment of diseases or disorders, such as organ injury or organ failure [33,34]. Thirteen genes involved in the biosynthesis of cyclosporin C were highly similar (identities and similarities > 80%) with the BGC of CsA from Tolypocladium inflatum NRRL 8004. Few fungi except Aspergillus terreus [35] had been reported to make cyclosporin agents, while others (Leptostroma, Cylindrotrichum, Stachybotrys) produce novel cyclosporin analogs [36]. The high similarity of these genes indicates that strain R1 has the capability to synthesize these motif-containing SMs. Furthermore, additional genes encoding P450 enzyme, dehydrogenase and protease in these BGCs endow this strain with the potential to biosynthesize more novel compounds. Additionally, 13 BGCs are predicted to code for single PKSs including 12 T1PKS and 1 T3PKS. However, only 3 PKSs located in regions 1.2, 53.1 and 72.1 displayed low similarities with known clusters responsible for the biosynthesis of duclauxin (GenBank accession no. EQ962653.1) [37], gibepyrone-A BGC (GenBank accession no. HF679033.1), oxyjavanicin (GenBank accession no. HE613440.1), respectively [38]. The function of other cryptic BGCs need to be further characterized by gene knockout experiment and heterogeneous expression, as well as LC-MS analysis.
In our previous chemical investigation of strain R1, two novel polyketides (Figure 7a,b) along with eleven known substances (Figure 7c–m) had been isolated and characterized (Figure 7) [39,40,41]. Antimicrobial tests showed that compound 1 had a potent inhibitory effect on Staphyloccocus aureus ATCC 2592 with a MIC value of 6.25 μM and compound 6 displayed weak anti-Helicobacter pylori capability at 16 μM. On basis of the antiSMASH analysis, compounds a–c, e–h and j–m were putatively biosynthesized by various PKSs, while compounds d and i were plausible products of the hybrid NRPS + PKS [42].

3. Materials and Methods

3.1. Microbes and Cultivation

The endophytic strain R1 was isolated and purified from the coastal plant Rumex madaio Makino, collected off Putuo Island (Zhoushan, China) [43]. A suspension of culture containing its mycelia in PDA supplemented with glycerol (20% v/v) was stored at −80 °C at Zhejiang University of Technology (Hangzhou, China).

3.2. Phylogenetic Analysis

For phylogenetic analysis, strain R1 was cultivated in a PDB medium at 28 °C for 3 days followed by 18S rRNA and ITS gene amplicon sequencing. Both the 18S rRNA sequence (GenBank accession no. MF376147) and ITS sequence (GenBank accession no. ON545070) were submitted to the NCBI databases. The phylogenetic analysis of strain R1 was delineated by a neighbor-joining phylogenetic tree which was constructed using the Tamura3-parameter model in MEGA7 with 1000 bootstrap replicates [44].

3.3. Genome Sequencing and Assembly

Strain R1 was grown on a PDA medium for 7 days at 28 °C. Genomic DNA was extracted following the CTAB extraction protocol, the concentration was verified fluorometrically using Gentra Puregene Yeast/Bact. Kit (Qiagen, Valencia, CA), the integrity and purity were assessed by 1% agarose gel electrophoresis and Nanodrop2000, and then dissolved in sterile water and adjusted to a concentration of 149 ng/μL. The 18S rRNA gene was amplified by PCR using the universal primers NS1 (5′-GTAGTCATATGCTTGTCTC-3′) and NS6 (5′-GCATCACAGACCTGTTATTGCCTC-3′). The PCR conditions included an initial denaturation at 94 °C for 15 min, followed by 30 cycles of 45 s at 94 °C, 90 s at 55 °C and 90 s at 72 °C; and a final extension at 72 °C for 10 min. Then to build and check the library, DNA libraries of a certain concentration and volume were added to each independent Flow cell, and the Flow cell was transferred to GridION X5 sequencer (Nanopore, Oxford, UK) for real-time single-molecule sequencing. Qubit (v2.0) was used for initial quantification, then the insert size of the library was detected using Agilent 2100, in order to ensure the quality of the library, Q-PCR was used to quantify the library’s effective concentration. The third-generation sequencing reads were assembled by HGAP (v4, http://www.pacb.com/devnet/, accessed on 10 December 2021) [45] and CANU (v1.7.1, https://canu.readthedocs.io/en/latest/, accessed on 20 December 2021) [46] software into contigs. The qualified library was sequenced by the paired-end Illumina HiSeq 2500, and the Raw Data obtained from the sequencing was used for post-processing information analysis. After the sequencing of genomic DNA, the Paired-end raw data were saved in FASTQ format. Quality control on Paired-end raw reads from next-generation sequencing data was performed using FastQC, the 3′ end of DNA adapter contamination was decontaminated with Adapter Removal protocol. At this point, raw data were filtered for high-quality adapter-free reads for genome assembly. For corrected read assembly, Unicycler (https://github.com/rrwick/Unicycler, accessed on 15 February 2022) was used to finalize the optimal assembly. Finally, Pilon software (v1.18, https://github.com/broadinstitute/pilon, accessed on 21 February 2022) was utilized to correct the third-generation contigs with the above-mentioned high-quality next-generation sequencing data and stitch them together to assemble a complete strain R1 genome sequence [47].

3.4. Gene Prediction and Annotation

Gene prediction was performed using Homology, SNAP and Augustus. Based on the gene function and metabolic pathway of the existing databases, the function annotation was performed by BLAST searches against these databases: NR (NCBI non-redundant protein sequences), Swiss-Prot, KEGG (Kyoto Encyclopedia of Genes and Genomes), COG (Cluster of Orthologous Groups of proteins), PHI (Pathogen Host Interactions Database), CAZy (Carbohydrate-Active Enzymes Database).

3.5. Analysis of Secondary Metabolite Biosynthetic Gene Clusters

SM biosynthetic gene cluster analysis of strain R1 was carried out by antiSMASH fungal 6.0.1 [48]. AntiSMASH can accurately identify all known secondary metabolic gene clusters when it can use a specific profile hidden Markov models [49]. In order to further study the obtained gene clusters, we used the NCBI Genome Portal Software Platform to conduct Blastp analysis and gene annotation, and then, concluded the gene clusters of secondary metabolites in strain R1.

4. Conclusions

Fusarium is a treasure trove of SMs with diverse chemical structures and biological properties [50]. In addition to phylogenetic analysis based on the 18S rRNA gene sequence, a high-quality whole-genome sequence of endophytic strain Fusarium sp. R1 from R. madaio Makino was obtained and extensively analyzed by gene prediction and annotation in this work. The results showed that strain R1 harbors abundant functional genes in energy production and conversion, amino acid transport and metabolism, carbohydrate transport and metabolism, secondary metabolites biosynthesis, transport and catabolism.
AntiSMASH analysis of strain R1 uncovered only 8 of 37 BGCs showed high similarity with known gene clusters, suggesting it had a vast potential for producing other SMs. Our previous chemical investigation indicated that most SMs produced by strain R1 under normal conditions are polyketides. Therefore, a great number of other types of BGCs of this strain are silent and/or expressed at a low level. These findings open possibilities for targeted genome mining such as gene knockout, introduction or heterologous expression of microbial genes, regulation of promoters, and induction of mutations to awaken these silent BGCs to biosynthesize more new bioactive SMs for new drug research and development [51].

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/metabo12060521/s1, Table S1: Putative biosynthetic gene clusters (BGCs) coding for secondary metabolites in strain R1. Table S2. Gene distribution of different fungi based on the six major modules of CAZymes. Figure S1. Phylogenetic tree of strain R1 based on 18S rRNA gene sequences aligned in NCBI standard database. Figure S2. Phylogenetic tree of strain R1 based on ITS gene sequences aligned in NCBI rRNA/ITS database.

Author Contributions

Conceptualization, project administration and funding acquisition, H.Z.; methodology, Y.L. and M.X.; software, Y.T.; formal analysis, Y.L. and H.Z.; investigation, Y.L., M.X. and Y.T.; resources, H.Z.; data curation, Y.S.; writing—original draft preparation, Y.L.; writing—review and editing, Y.L., H.W. and H.Z. All authors have read and agreed to the published version of the manuscript.

Funding

This work was co-financially supported by the National Key Research and Development Program of China (2018YFC0311004), the National Natural Science Foundation of China (41776139) and the Fundamental Research Fund for the Provincial Universities of Zhejiang of China (RF-C2019002).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

The data presented in this study are available in supplementary material.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Carroll, A.R.; Copp, B.R.; Davis, R.A.; Keyzers, R.A.; Prinsep, M.R. Marine natural products. Nat. Prod. Rep. 2020, 37, 175–223. [Google Scholar] [CrossRef]
  2. Venugopalan, A.; Srivastava, S. Endophytes as in vitro production platforms of high value plant secondary metabolites. Biotechnol. Adv. 2015, 33, 873–887. [Google Scholar] [CrossRef]
  3. Zhang, H.; Bai, X.; Zhang, M.; Chen, J.; Wang, H. Bioactive natural products from endophytic microbes. Nat. Prod. J. 2018, 8, 86–108. [Google Scholar] [CrossRef]
  4. Andrea, S.; Gary, S.; Donald, S. Taxol and taxane production by Taxomyces andreanae, an endophytic fungus of Pacific Yew. Science 1993, 260, 214–216. [Google Scholar]
  5. Dweba, C.C.; Figlan, S.; Shimelis, H.A.; Motaung, T.E.; Sydenham, S.; Mwadzingeni, L.; Tsilo, T.J. Fusarium head blight of wheat: Pathogenesis and control strategies. Crop Prot. 2017, 91, 114–122. [Google Scholar] [CrossRef]
  6. Champaco, E.R.; Mrtyn, R.D.; Miller, M.E. Comparison of Fusarium solani and F. oxysporum as causal agents of fruit rot and root rot of muskmelon. Hortscience 1993, 28, 1174–1177. [Google Scholar] [CrossRef] [Green Version]
  7. Wang, Q.X.; Li, S.F.; Zhao, F.; Dai, H.Q.; Bao, L.; Ding, R.; Gao, H.; Zhang, L.X.; Wen, H.A.; Liu, H.W. Chemical constituents from endophytic fungus Fusarium oxysporum. Fitoterapia 2011, 82, 777–781. [Google Scholar] [CrossRef]
  8. Kyekyeku, J.O.; Kusari, S.; Adosraku, R.K.; Bullach, A.; Golz, C.; Strohmann, C.; Spiteller, M. Antibacterial secondary metabolites from an endophytic fungus, Fusarium solani JK10. Fitoterapia 2017, 119, 108–114. [Google Scholar] [CrossRef]
  9. Sakai, A.; Suzuki, C.; Masui, Y.; Kuramashi, A.; Takatori, K.; Tanaka, N. The activities of mycotoxins derived from Fusarium and related substances in a short-term transformation assay using v-Ha-ras-transfected BALB/3T3 cells (Bhas 42 cells). Mutat. Res. 2007, 630, 103–111. [Google Scholar] [CrossRef]
  10. Lee, D.; Shim, S.; Kang, K. 4,6′-anhydrooxysporidinone from Fusarium lateritium SSF2 induces autophagic and apoptosis cell death in MCF-7 breast cancer cells. Biomolecules 2021, 11, 869. [Google Scholar] [CrossRef]
  11. Dame, Z.T.; Silima, B.; Gryzenhout, M.; van Ree, T. Bioactive compounds from the endophytic fungus Fusarium proliferatum. Nat. Prod. Res. 2016, 30, 1301–1304. [Google Scholar] [CrossRef]
  12. Alsufiani, H.; Ashour, W. Effectiveness of the natural antioxidant 2,4,4′-Trihydroxychalcone on the oxidation of sunflower oil during storage. Molecules 2021, 26, 1630. [Google Scholar] [CrossRef]
  13. Caicedo, N.H.; Davalos, A.F.; Puente, P.A.; Rodriguez, A.Y.; Caicedo, P.A. Antioxidant activity of exo-metabolites produced by Fusarium oxysporum: An endophytic fungus isolated from leaves of Otoba gracilipes. Microbiologyopen 2019, 8, e903. [Google Scholar] [CrossRef] [Green Version]
  14. Russell, A.H.; Truman, A.W. Genome mining strategies for ribosomally synthesised and post-translationally modified peptides. Comput. Struct. Biotechnol. J. 2020, 18, 1838–1851. [Google Scholar] [CrossRef]
  15. Blin, K.; Kim, H.U.; Medema, M.H.; Weber, T. Recent development of antiSMASH and other computational approaches to mine secondary metabolite biosynthetic gene clusters. Brief. Bioinform. 2019, 20, 1103–1113. [Google Scholar] [CrossRef]
  16. Li, M.; Yu, R.; Bai, X.; Wang, H.; Zhang, H. Fusarium: A treasure trove of bioactive secondary metabolites. Nat. Prod. Rep. 2020, 37, 1568–1588. [Google Scholar] [CrossRef]
  17. Weber, S.D.; Hofmann, A.; Pilhofer, M.; Wanner, G.; Agerer, R.; Ludwig, W.; Schleifer, K.H.; Fried, J. The diversity of fungi in aerobic sewage granules assessed by 18S rRNA gene and ITS sequence analyses. FEMS Microbiol. Ecol. 2009, 68, 246–254. [Google Scholar] [CrossRef]
  18. Schoch, C.L.; Seifert, K.A.; Huhndorf, S.; Robert, V.; Spouge, J.L.; Levesque, C.A.; Chen, W.; Fungal Barcoding, C.; Fungal Barcoding Consortium Author, L. Nuclear ribosomal internal transcribed spacer (ITS) region as a universal DNA barcode marker for Fungi. Proc. Natl. Acad. Sci. USA 2012, 109, 6241–6246. [Google Scholar] [CrossRef] [Green Version]
  19. Natale, D.A.; Shankavaram, U.T.; Galperin, M.Y.; Wolf, Y.I.; Aravind, L.; Koonin, E.V. Towards understanding the first genome sequence of a crenarchaeon by genome annotation using clusters of orthologous groups of proteins (COGs). Genome Biol. 2000, 1, 5. [Google Scholar] [CrossRef] [Green Version]
  20. Yamada, Y.; Hirakawa, H.; Hori, K.; Minakuchi, Y.; Toyoda, A.; Shitan, N.; Sato, F. Comparative analysis using the draft genome sequence of California poppy (Eschscholzia californica) for exploring the candidate genes involved in benzylisoquinoline alkaloid biosynthesis. Biosci. Biotechnol. Biochem. 2021, 85, 851–859. [Google Scholar] [CrossRef]
  21. Huntley, R.P.; Harris, M.A.; Alam-Faruque, Y.; Blake, J.A.; Seth, C.; Dietze, H.; Dimmer, E.C.; Foulger, R.E.; Hill, D.P.; Khodiyar, V.K.; et al. A method for increasing expressivity of Gene Ontology annotations using a compositional approach. BMC Bioinf. 2014, 15, 155. [Google Scholar] [CrossRef] [Green Version]
  22. Urban, M.; Cuzick, A.; Seager, J.; Wood, V.; Rutherford, K.; Venkatesh, S.Y.; Sahu, J.; Iyer, S.V.; Khamari, L.; De Silva, N.; et al. PHI-base in 2022: A multi-species phenotype database for Pathogen–Host Interactions. Nucleic Acids Res. 2022, 50, D837–D847. [Google Scholar] [CrossRef]
  23. Pernas, L. Cellular metabolism in the defense against microbes. J. Cell Sci. 2021, 134, jcs252023. [Google Scholar] [CrossRef]
  24. Garron, M.L.; Henrissat, B. The continuing expansion of CAZymes and their families. Curr. Opin. Chem. Biol. 2019, 53, 82–87. [Google Scholar] [CrossRef]
  25. Drula, E.; Garron, M.L.; Dogan, S.; Lombard, V.; Henrissat, B.; Terrapon, N. The carbohydrate-active enzyme database: Functions and literature. Nucleic Acids Res. 2022, 50, D571–D577. [Google Scholar] [CrossRef]
  26. Xu, L.; Li, Y.; Biggins, J.B.; Bowman, B.R.; Verdine, G.L.; Gloer, J.B.; Alspaugh, J.A.; Bills, G.F. Identification of cyclosporin C from Amphichorda felina using a Cryptococcus neoformans differential temperature sensitivity assay. Appl. Microbiol. Biotechnol. 2018, 102, 2337–2350. [Google Scholar] [CrossRef] [Green Version]
  27. Donzelli, B.G.G.; Krasnoff, S.B.; Churchill, A.C.L.; Vandenberg, J.D.; Gibson, D.M. Identification of a hybrid PKS–NRPS required for the biosynthesis of NG-391 in Metarhizium robertsii. Curr. Genet. 2010, 56, 151–162. [Google Scholar] [CrossRef]
  28. Romans-Fuertes, P.; Sondergaard, T.E.; Sandmann, M.I.; Wollenberg, R.D.; Nielsen, K.F.; Hansen, F.T.; Giese, H.; Brodersen, D.E.; Sorensen, J.L. Identification of the non-ribosomal peptide synthetase responsible for biosynthesis of the potential anti-cancer drug sansalvamide in Fusarium solani. Curr. Genet. 2016, 62, 799–807. [Google Scholar] [CrossRef]
  29. Gilbert, N.B.; Paul, R.J.; William, F. Sansalvamide: A new cytotoxic cyclic depsipeptide produced by a marine fungus of the genus Fusarium. Tetrahedron Lett. 1999, 40, 2913–2916. [Google Scholar]
  30. Lawrence, A.W.; Leonard, F.B. Fusarin C, a mutagen from Fusarium Moniliforme grown on corn. J. Food Sci. 1981, 46, 1424–1426. [Google Scholar]
  31. Gelderblom, W.C.; Thiel, P.G.; van der Merwe, K.J. The chemical and enzymatic interaction of glutathione with the fungal metabolite, fusarin C. Mutat. Res. 1988, 199, 207–214. [Google Scholar] [CrossRef]
  32. Krasnoff, S.B.; Sommers, C.H.; Moon, Y.-S.; Donzelli, B.G.G.; Vandenberg, J.D.; Churchill, A.C.L.; Gibson, D.M. Production of mutagenic metabolites by Metarhizium anisopliae. J. Agric. Food Chem. 2006, 54, 7083–7088. [Google Scholar] [CrossRef]
  33. Weber, G.; Schorgendorfer, K.; Schneiderscherzer, E.; Leitner, E. The peptide synthetase catalyzing cyclosporine production in Tolypocladium niveum is encoded by a giant 45.8-kilobase open reading fram. Curr. Genet. 1994, 26, 120–125. [Google Scholar] [CrossRef]
  34. Hoffmeister, D.; Keller, N.P. Natural products of filamentous fungi: Enzymes, genes, and their regulation. Nat. Prod. Rep. 2007, 24, 393–416. [Google Scholar] [CrossRef]
  35. Sallam, L.; El-Refai, A.; Hamdy, A.; El-Minofi, H.; Abdel-Salam, I. Role of some fermentation parameters on cyclosporin A production by a new isolate of Aspergillus terreus. J. Gen. Appl. Microbiol. 2003, 49, 321–328. [Google Scholar]
  36. Sakamoto, K.; Tsujii, E.; Miyauchi, M.; Nakanishi, T.; Yamashita, M.; Shigematsu, N.; Tada, T.; Izumi, S.; Okuhara, M. FR901459, a novel immunosuppressant isolated from Stachybotrys chartarum No. 19392. Taxonomy of the producing organism, fermentation, isolation, physico-chemical properties and biological activities. J. Antibiot. 1993, 46, 1788–1798. [Google Scholar] [CrossRef]
  37. Studt, L.; Wiemann, P.; Kleigrewe, K.; Humpf, H.U.; Tudzynski, B. Biosynthesis of fusarubins accounts for pigmentation of Fusarium fujikuroi perithecia. Appl. Environ. Microbiol. 2012, 78, 4468–4480. [Google Scholar] [CrossRef] [Green Version]
  38. Pedersen, T.B.; Nielsen, M.R.; Kristensen, S.B.; Spedtsberg, E.M.L.; Yasmine, W.; Matthiesen, R.; Kaniki, S.E.K.; Sorensen, T.; Petersen, C.; Muff, J.; et al. Heterologous expression of the core genes in the complex fusarubin gene cluster of Fusarium Solani. Int. J. Mol. Sci. 2020, 21, 7601. [Google Scholar] [CrossRef]
  39. Fu, Z.; Liu, Y.; Xu, M.; Yao, X.; Wang, H.; Zhang, H. Absolute configuration determination of two diastereomeric neovasifuranones A and B from Fusarium oxysporum R1 by a combination of Mosher’s method and chiroptical approach. J. Fungi 2021, 8, 40. [Google Scholar] [CrossRef]
  40. Yu, R.; Li, M.; Wang, Y.; Bai, X.; Chen, J.; Li, X.; Wang, H.; Zhang, H. Chemical investigation of a co-culture of Aspergillus fumigatus D and Fusarium oxysporum R1. Rec. Nat. Prod. 2020, 15, 130–135. [Google Scholar] [CrossRef]
  41. Chen, J.; Bai, X.; Hua, Y.; Zhang, H.; Wang, H. Fusariumins C and D, two novel antimicrobial agents from Fusarium oxysporum ZZP-R1 symbiotic on Rumex madaio Makino. Fitoterapia 2019, 134, 1–4. [Google Scholar] [CrossRef]
  42. Furumoto, T.; Hamasaki, T.; Nakajima, H. Biosynthesis of phytotoxin neovasinin and its related metabolites, neovasipyrones A and B and neovasifuranones A and B, in the phytopathogenic fungus Neocosmospora vasinfecta. J. Chem. Soc. Perkin Trans. 1999, 1, 131–135. [Google Scholar] [CrossRef]
  43. Bai, X.; Yu, R.; Li, M.; Zhang, H. Antimicrobial assay of endophytic fungi from Rumex madaio and chemical study of strain R1. Bangl. J. Pharmacol. 2019, 14, 129–135. [Google Scholar] [CrossRef]
  44. Kumar, S.; Stecher, G.; Tamura, K. MEGA7: Molecular Evolutionary Genetics Analysis Version 7.0 for Bigger Datasets. Mol. Biol. Evol. 2016, 33, 1870–1874. [Google Scholar] [CrossRef] [Green Version]
  45. Chin, C.S.; Peluso, P.; Sedlazeck, F.J.; Nattestad, M.; Concepcion, G.T.; Clum, A.; Dunn, C.; O’Malley, R.; Figueroa-Balderas, R.; Morales-Cruz, A.; et al. Phased diploid genome assembly with single-molecule real-time sequencing. Nat. Methods 2016, 13, 1050–1054. [Google Scholar] [CrossRef] [Green Version]
  46. Koren, S.; Walenz, B.P.; Berlin, K.; Miller, J.R.; Bergman, N.H.; Phillippy, A.M. Canu: Scalable and accurate long-read assembly via adaptive k-mer weighting and repeat separation. Genome Res. 2017, 27, 722–736. [Google Scholar] [CrossRef] [Green Version]
  47. Walker, B.J.; Abeel, T.; Shea, T.; Priest, M.; Abouelliel, A.; Sakthikumar, S.; Cuomo, C.A.; Zeng, Q.; Wortman, J.; Young, S.K.; et al. Pilon: An integrated tool for comprehensive microbial variant detection and genome assembly improvement. PLoS ONE 2014, 9, e112963. [Google Scholar] [CrossRef]
  48. Blin, K.; Shaw, S.; Kloosterman, A.M.; Charlop-Powers, Z.; van Wezel, G.P.; Medema, M.H.; Weber, T. AntiSMASH 6.0: Improving cluster detection and comparison capabilities. Nucleic Acids Res. 2021, 49, W29–W35. [Google Scholar] [CrossRef]
  49. Blin, K.; Medema, M.H.; Kottmann, R.; Lee, S.Y.; Weber, T. The antiSMASH database, a comprehensive database of microbial secondary metabolite biosynthetic gene clusters. Nucleic Acids Res. 2017, 45, D555–D559. [Google Scholar] [CrossRef] [Green Version]
  50. Hoogendoorn, K.; Barra, L.; Waalwijk, C.; Dickschat, J.S.; van der Lee, T.A.J.; Medema, M.H. Evolution and diversity of biosynthetic gene clusters in Fusarium. Front. Microbiol. 2018, 9, 1158. [Google Scholar] [CrossRef] [Green Version]
  51. Pan, R.; Bai, X.; Chen, J.; Zhang, H.; Wang, H. Exploring structural diversity of microbe secondary metabolites using OSMAC strategy: A literature review. Front. Microbiol. 2019, 10, 294. [Google Scholar] [CrossRef] [Green Version]
Metabolites 12 00521 g001 550
Figure 1. Colony (a) and microscopic (b) morphology of strain R1.
Figure 1. Colony (a) and microscopic (b) morphology of strain R1.
Metabolites 12 00521 g001
Metabolites 12 00521 g002 550
Figure 2. Genome diagram of strain R1.
Figure 2. Genome diagram of strain R1.
Metabolites 12 00521 g002
Metabolites 12 00521 g003a 550Metabolites 12 00521 g003b 550
Figure 3. Functional annotation of strain R1 genes encoding the proteins: (a) Orthologous Groups of proteins (COG) analysis; (b) Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis; (c) Gene Ontology (GO) analysis.
Figure 3. Functional annotation of strain R1 genes encoding the proteins: (a) Orthologous Groups of proteins (COG) analysis; (b) Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis; (c) Gene Ontology (GO) analysis.
Metabolites 12 00521 g003aMetabolites 12 00521 g003b
Metabolites 12 00521 g004 550
Figure 4. Distribution map of mutation types in the pathogen PHI phenotype of strain R1.
Figure 4. Distribution map of mutation types in the pathogen PHI phenotype of strain R1.
Metabolites 12 00521 g004
Metabolites 12 00521 g005 550
Figure 5. CAZy functional classification and the number of corresponding genes of strain R1.
Figure 5. CAZy functional classification and the number of corresponding genes of strain R1.
Metabolites 12 00521 g005
Metabolites 12 00521 g006a 550Metabolites 12 00521 g006b 550
Figure 6. Comparison of BGC constituents in strain R1 with identified BGCs for biosynthesis of sansalvamide (a), NG-391 (b) and cyclosporin C (c).
Figure 6. Comparison of BGC constituents in strain R1 with identified BGCs for biosynthesis of sansalvamide (a), NG-391 (b) and cyclosporin C (c).
Metabolites 12 00521 g006aMetabolites 12 00521 g006b
Metabolites 12 00521 g007 550
Figure 7. Thirteen secondary metabolites (a–m) previously discovered from strain R1.
Figure 7. Thirteen secondary metabolites (a–m) previously discovered from strain R1.
Metabolites 12 00521 g007
Table
Table 1. Genomic assembly and functional annotation of strain R1 genome.
Table 1. Genomic assembly and functional annotation of strain R1 genome.
ItemValueItemCountPercentage (%)
Total length (bp)51,784,516All17,14588.68
Max length (bp)6,563,362NR16,80386.91
GC content (%)50.4NT15,46179.97
Gene number19,333Swiss-Prot11,02657.03
Gene total length (bp)24,687,144KEGG10,89456.35
Gene average length (bp)1276.94COG804841.63
GC content in gene region (%)55.06GO878045.41
Gene/Genome (%)47.67
Contigs542
N50 (bp)3,209,824
N90 (bp)1,367,080
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Liu, Y.; Xu, M.; Tang, Y.; Shao, Y.; Wang, H.; Zhang, H. Genome Features and AntiSMASH Analysis of an Endophytic Strain Fusarium sp. R1. Metabolites 2022, 12, 521. https://doi.org/10.3390/metabo12060521

AMA Style

Liu Y, Xu M, Tang Y, Shao Y, Wang H, Zhang H. Genome Features and AntiSMASH Analysis of an Endophytic Strain Fusarium sp. R1. Metabolites. 2022; 12(6):521. https://doi.org/10.3390/metabo12060521

Chicago/Turabian Style

Liu, Yuanyuan, Meijie Xu, Yuqi Tang, Yilan Shao, Hong Wang, and Huawei Zhang. 2022. "Genome Features and AntiSMASH Analysis of an Endophytic Strain Fusarium sp. R1" Metabolites 12, no. 6: 521. https://doi.org/10.3390/metabo12060521

APA Style

Liu, Y., Xu, M., Tang, Y., Shao, Y., Wang, H., & Zhang, H. (2022). Genome Features and AntiSMASH Analysis of an Endophytic Strain Fusarium sp. R1. Metabolites, 12(6), 521. https://doi.org/10.3390/metabo12060521

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop